The problems that general practitioners experience in treating these women, who are solely in their care, are due to many causes,3 some ofwhich were mentioned by Collinge.9 But general practitioners are not the only ones failing to give anti-D immunoglobulin in early pregnancy. From the results of a postal survey Contreras et al reported on ambivalent attitudes among some haematologists and obstetricians.'0 Entwistle et al suggested that all women who cannot readily be grouped should be given anti-D immunoglobulin.2 This would mean that of every seven doses given six would be wasted on Rh positive women. Anti-D immunoglobulin is available in our area only from the hospital fridge on a named patient basis. It is still in short supply, and this was discussed in two letters to the BM. 1 12
Some of the confusion that now surrounds us might have been avoided if all reports had clearly stated the type of "abortion" that was causing new sensitisations. Abortion is an ugly word and heartily disliked by our patients. If we use it ambiguously it will never serve us well, and perhaps we should now abandon it.
In order to see the problem more clearly would it be possible in future for haematologists to report separately the number ofwomen who become sensitised after (i) threatened miscarriages (early and late), (ii) spontaneous miscarriages (treated conservatively or with curettage), and (iii) the termination of unwanted pregnancies? Only when general practitioners are given this information will we fully understand when anti-D immunoglobulin is required, and it would encourage us to make the extra effort (where necessary) to identify and protect those Rh negative women who are greatly at risk. It is difficult to obtain decisive evidence about transplacental haemorrhage after early terminations of pregnancy. This is partly because of the increase in fetal haemoglobin concentration in maternal cells, which may occur as early as the eighth week of pregnancy and which makes it almost impossible to detect small numbers of fetal cells with certainty, and partly because the amounts of fetal blood in the maternal circulation must in any case be very small. In one study in which an attempt was made to estimate the extent of transplacental haemorrhage after induced termination of pregnancy haemorrhage was estimated to be greater than 005 ml in 5% of cases and greater than 05 ml in 2%, whereas after spontaneous miscarriages it was always less than 0 05 ml. ' Even 0 03 ml of red cells, however, may be enough to induce Rh immunisation. ' Evidence that spontaneous miscarriages occurring in the first trimester can, in fact, initiate Rh immunisation scarcely exists. In one series of women who had not been given anti-D immunoglobulin after an abortion occurring during the first 12 weeks of pregnancy and who developed anti-Rh during the following pregnancy3 (supplemented by L A D Tovey, personal communication) there were eight in whom the miscarriage had been spontaneous. In these eight women anti-Rh developed only during the last weeks of the succeeding pregnancy and might have been initiated by the second pregnancy rather than by the miscarriage. Although there is little evidence that spontaneous miscarriage occurring in the first 12 weeks can initiate Rh immunisation, there is plenty of evidence that induced termination of pregnancy occurring as early as 12 weeks can do so.2
More information about the risk of Rh immunisation after spontaneous miscarriage may eventually become available from careful observations on women who for whatever reason have not been given anti-D immunoglobulin. Meanwhile, it might be a good rule to say that anti-D immunoglobulin should be given whenever the spontaneous miscarriage occurs later than 12 weeks. This rule is, of course, somewhat arbitrary but reflects the fact that the extent of transplacental haemorrhage increases as pregnancy advances. If the woman has no living child it is of course particularly important to take all possible steps to prevent Rh immunisation.
I do not agree with the suggestion of giving Rh immunoglobulin to all women after sensitising episodes if the Rh group is not known. It should be possible for the ABO and Rh groups of all pregnant women to be known at an early stage regardless of threatened or actual miscarriage. Such information would help to ensure that Rh negative women were given anti-D immunoglobulin after terminations of pregnancy, ectopic pregnancies, amniocenteses, versions, and so on.
Although the importance of giving anti-D immunoglobulin to previously unimmunised Rh negative women after any episode known to carry a substantial risk of inducing immunisation is accepted, it does not seem necessary to give anti-D immunoglobulin to women after spontaneous abortion in the first trimester of pregnancy. THEO-and THEOBROMINE. Although the "theo"-moiety occurs in the names of both these pharmacologically related substances, the roots are unrelated. The name Theobroma (Gk theos, god + Gk broma, food) was chosen by Linnaeus (1760) to denote the genus of which one species, T cacao, yields seeds that are the source of cocoa and chocolate. In the seventeenth and eighteenth centuries chocolate was a very highly regarded beverage, and "food of the gods" would have been an appropriate epithet. THEOPHYLLINE (mod L thea, tea + combining "o" + Gkphyllon, leaf) was first obtained from tea leaves. The main alkaloid in tea, however, is caffeine, so named from its presence also in coffee. Of the methylxanthines, caffeine is the most potent as a cerebral stimulant. Xanthine, incidentally, is named after the yellow compound yielded with nitric acid (Gk xanthos, yellow).
BROM-We have seen that there is no bromine in theobromine. Yet the "-brom-" moiety in pharmacological terms almost always denotes the presence of that element (Gk bromos, stink) (19 March, page 835). The BROMIDES of sodium, potassium, and ammonium were the most widely used sedatives before being displaced by the barbiturates in the third decade of th%e twentieth century. Bromine is present in many a pharmaceutical molecule, most recently perhaps in the ergot derivative, BROMOCRIPTINE.
Other "brom-" lookalikes are the BROMES (Gk bromos, oats; yes, the Greeks also had their homonyms), a species of grass. Hubbard describes 12 common British varieties,' only one of which, Upright Brome, is of value as fodder. All bromes may provoke hay fever (seasonal allergic rhinitis) when producing pollen-a condition which, by a kind of poetic justice, may be treated with the bromine containing antihistamine, 
